These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 575499)

  • 41. [Cardiac electrophysiologic effect of various catecholamines and parasympatholytic agents].
    Bischoff KO
    Fortschr Med; 1982 Sep; 100(35):1618-21. PubMed ID: 7173768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electrophysiological studies on the effect of cordarone].
    Piwowarska W; Sniezek-Maciejewska M; Szczepkowski J
    Kardiol Pol; 1984; 27(3):181-9. PubMed ID: 6737834
    [No Abstract]   [Full Text] [Related]  

  • 43. The electrophysiology of Norpace (Part I).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of disopyramide on normal and pathological atrioventricular conduction].
    Barnay C
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):449-53. PubMed ID: 1298185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ.
    Landmark K; Amlie JP
    Eur J Cardiol; 1976 Dec; 4(4):419-27. PubMed ID: 1001337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of creatinol-O-phosphate (COP) on haemodynamics and cardiac metabolism in conscious and anaesthetized dogs.
    Marchetti G; Merlo L
    Arzneimittelforschung; 1978; 28(10):1708-11. PubMed ID: 582673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The electrophysiologic properties of esmolol, a short acting beta-blocker.
    Greenspan AM; Spielman SR; Horowitz LN; Laddu A; Senior S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):209-16. PubMed ID: 2900217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Functional indices of the heart conduction system in patients with normal atrioventricular conduction].
    Sokolov SF; Golitsyn SP; Petrovskiĭ PF; Miasnikov OA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):7-17. PubMed ID: 7138659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
    Rowland E; McKenna WJ; Gülker H; Krikler DM
    Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concealed re-entry in the human heart.
    Littmann L; Tenczer J; Fenyvesi T; Rohla M; Svenson RH
    Acta Med Acad Sci Hung; 1982; 39(1-2):31-8. PubMed ID: 7180359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolongation of cardiac conduction times by intravenous aprindine in man.
    Greene HL; Reid PR; Schaeffer AH
    Am J Cardiol; 1978 Dec; 42(6):1002-6. PubMed ID: 727127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of lidocaine and methyl lidocaine on cardiac conduction.
    Man RY; Dresel PE
    J Pharmacol Exp Ther; 1977 Apr; 201(1):184-91. PubMed ID: 850138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Electrophysiologic properties of diltiazem VUFB tablets: effect on atrioventricular conduction].
    Mádle A; Vainer J; Kudová J; Smíd J; Mastálka J
    Vnitr Lek; 1989 May; 35(5):445-51. PubMed ID: 2763477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of procainamide on reentry within the His-Purkinje system in man.
    Reddy CP; Damato AN; Akhtar M; Dhatt MS; Gomes JA; Calon AH
    Am J Cardiol; 1977 Dec; 40(6):957-64. PubMed ID: 930843
    [No Abstract]   [Full Text] [Related]  

  • 56. Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effects of digitalis.
    Rosen MR; Wit AL; Hoffman BF
    Am Heart J; 1975 Mar; 89(3):391-9. PubMed ID: 1090138
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis and chemical properties of N- and O-phosphorylated derivatives of creatinol.
    Ferrari G; Casagrande C
    Arzneimittelforschung; 1979; 29(9a):1446-9. PubMed ID: 575489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
    Godfraind T; Ghysel-Burton J; Sturbois X
    Arzneimittelforschung; 1979; 29(9a):1468-70. PubMed ID: 575494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
    Guglielmi G; Mammarella A
    Clin Ter; 1979 Nov; 91(4):355-82. PubMed ID: 396100
    [No Abstract]   [Full Text] [Related]  

  • 60. The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias.
    Reid DS
    Br J Clin Pharmacol; 1978 Dec; 6(6):473-85. PubMed ID: 365208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.